Tarsus Pharmaceuticals, Inc. — Director's Dealing 2021

Aug 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tarsus Pharmaceuticals, Inc. (TARS)
CIK: 0001819790
Period of Report: 2021-08-11

Reporting Person: Crane Rosemary A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-11	Stock Option (right to buy)	$25.05	A	20000	Acquired	2031-08-11	Common Stock (20000)	Direct

Footnotes

F1: The option shares vest in 3 annual installments beginning on August 11, 2022, subject to the Reporting Person's continuous service.